NA Proactive news snapshot: Bioasis Technologies, OTC Markets Group, Phyto Therapeutics, NexTech AR Solutions UPDATE ...

Bioasis Technologies Inc (CVE:BTI) (OTCQB:BIOAF) has reached a royalty purchase agreement with XOMA Corporation to sell certain rights to milestone and royalty revenue from the advancement of four enzymes the company is investigating as a treatment for lysosomal storage disorders (LSD). The enzymes are being developed under Bioasis’ strategic alliance with Chiesi Group, the company said. In exchange for a US$1.2 million upfront payment, XOMA will receive a low single-digit royalty on future net sales of each of the four enzymes and an undisclosed share of the up to US$138 million in potential milestones made possible by the Bioasis-Chiesi Group alliance. Virtual Investor Conferences, the proprietary virtual event series from OTC Markets Group Inc (OTCQX:OTCM), has released the agenda for its upcoming Retail/Consumer/Digital Goods and Services Virtual lnvestor Conference on Thursday, November 5. The free event is designed to connect investors, analysts, and advisors with senior representatives from a variety of companies in the consumer and digital goods and services sectors. The conference is scheduled to begin at 9:15 am ET with the first webcast beginning at 9:30 am. Phyto Therapeutics Corp (CSE:XPHY) (OTCMKTS:XPHYF) (FRA:4XT) said Tuesday that its German subsidiary Vektor Pharma TF GmbH will start to develop a process to manufacture psilocybin as a certified active pharmaceutical ingredient (API). The subsidiary inked a research agreement with a leading German university that will see Vektor exclusively develop a proprietary process for industrial production of psilocybin, Vancouver-based XPhyto told investors. In a statement, XPhyto said it is currently focused on securing industrial-scale production of psychedelic APIs and standardizing drug formulations. A biotechnology production program started last month and is expected to finish around September 2021.  NexTech AR Solutions Corp (OTCQB:NEXCF) (CSE:NTAR) (FRA:N29) announced Friday that it is expanding its services into the Asia-Pacific market after establishing a presence in Singapore. To support this expansion, NexTech said it has hired Yau Boon Lim, a technology industry veteran with over 25 years’ experience in strategy, planning, marketing, operations, and business management for various industries in the Asia-Pacific market. Lim has held leadership positions within global enterprise technology companies, driving marketing and strategies for blue-chip global tech companies, including IBM, where he led marketing management, Motorola where he was head of strategy and planning, and SAP where he was vice president of marketing for the Asia-Pacific market. Lim will be based out of Singapore. In this new role, Lim will be responsible for quickly establishing NexTech’s presence in the Asia-Pacific market through strategic channel partnerships. Lim will also drive the company’s marketing efforts across Asia and will build out the team to support service requests across the region by the end of 2020. Energy Fuels Inc (TSE:EFR) (NYSE American:UUUU) announced that it has produced a rare earth element (REE) carbonate concentrate on a pilot scale at its 100% owned White Mesa Mill in Utah. Energy Fuels said, to the best of its knowledge, that this is the first REE concentrate produced from monazite sands at any significant quantity in North America in more than 20 years. Monazite sands are a part of the uranium ore, which also contain high concentrations of REEs. Nova Royalty Corp (CVE:NOVR) announced a pair of additions to its ranks Tuesday, bringing on EB Tucker as an independent director and Bill Tsang as CFO, both effective immediately. Tucker is currently an independent director of Metalla Royalty & Streaming (NYSE:MTA). Bill Tsang is a CPA with more than 10 years of financial accounting and auditing experience in the mineral exploration and mining industry. Nova also announced that it has filed a final short form base shelf prospectus with regulatory authorities in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick and Nova Scotia.  CleanSpark Inc (NASDAQ:CLSK) announced Monday that it will be one of the Platinum Sponsors at the upcoming Microgrid Knowledge 2020 Global Conference on November 17-19.  The company said this is the largest conference that focuses solely on microgrids, and it will have hundreds of decision-makers from all aspects of the industry in attendance. Participants are expected to represent utilities, developers, and policymakers interested in microgrids and advanced distributed energy solutions. As a Platinum Sponsor, CleanSpark said it will be provided with a number of featured placements within the conference communication and virtual tradeshow environment. Pacific Empire Minerals Corp (CVE:PEMC) (OTCQB:PEMSF), the prospect generator, revealed it had hired OreQuest Consultants Ltd and its significant mining industry expertise to advance its Jean Marie project and other assets in its portfolio. George Cavey and Douglas Cavey along with Jennifer Roskowski have been appointed as technical advisors, the group said in a statement. Initially, the team will review all data gathered to date from the Jean Marie copper-gold project in British Columbia, and design the exploration program there following the receipt, announced last month, of the exploration permit. Goldseek Resources Inc (CSE:GSK) said Tuesday that survey results from its Bonanza property in Quebec have defined new surface trenching and preliminary drill targets. The results of the induced polarization survey will help Goldseek to plan an upcoming drill program at Bonanza that is anticipated to begin in December. A team is onsite and trenching is already underway on the anomalies that extend to the surface, the junior company told shareholders. Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCQB:NSPDF) announced that it has received a Notice of Authorization from Health Canada to proceed with a Phase 2 clinical trial for a potential COVID-19 treatment utilizing the target drug Cavaltinib. Cavaltinib has been shown to inhibit cytokines, small proteins released by many different cells in the body, including those of the immune system where they coordinate the immune and inflammatory response against infection or other triggers, according to the company, which believes Cavaltinib will show the same positive results in mitigating the 'cytokine storm' with COVID-19 patients.  Group Eleven Resources Corp (CVE:ZNG) (OTCMKTS:GRLVF) (FRA:3GE) told investors that three prospects have been 'significantly' advanced by its latest drilling at the PG West zinc project in the Republic of Ireland.  The company said five holes for more than 1,000 metres (m) on early-stage targets were completed at the wholly-owned project, which spans 1,005 square kilometers (sq km) and lies within the Limerick basin, which also hosts the company's contiguous 76.56%-owned Stonepark project and Glencore's adjacent Pallas Green project. The property is also home to the Carrickittle prospect, where drilling is on track and results are expected in coming weeks, added the company. Humanigen Inc (NASDAQ:HGEN) (FRA:0KB2) announced Tuesday that it has signed a licensing agreement with Telcon RF Pharmaceutical Inc and KPM Tech Co Ltd for the development and commercialization rights to its drug lenzilumab as a coronavirus (COVID-19) treatment in South Korea and the Philippines. The deal is worth as much as $20 million, including $6 million in an upfront payment when the agreement is executed and $14 million in two payments when certain achievement milestones are met by Humanigen in the US. Telcon and KPM Tech will be responsible for gaining regulatory approval and subsequent commercialization of lenzilumab in its territories, and Humanigen will earn double-digit royalties following such approval on net sales after commercialization.  NetCents Technology Inc (CSE:NC) (OTCQB:NTTCF) (FRA:26N), a cryptocurrency payments company, announced on Tuesday that it is adding the ability for NetCents users to purchase cryptocurrency by dint of a credit card on the NC Exchange. The Vancouver-based company noted that there are a limited number of platforms that are approved by the card companies for purchasing cryptocurrency. “NetCents is now approved, which is a testament to the safety that is inherent in the NetCents platform,” said the company in a statement. The company said the move would be benefecial as it would provide a new way for users to be able to load funds into their NetCents wallet, making it easier for users to purchase cryptocurrency. In addition, it will provide NetCents users with fast and easy access to cryptocurrency, in the most secure way possible. Gold Resource Corporation (NYSEAMERICAN:GORO) (FRA:GIH) told investors it generated free cash flow at both its mining operations in the third quarter this year despite a two-month shut-down of operations in Mexico from April. The company is a gold and silver producer and explorer with mines in Oaxaca, Mexico and Nevada in the US. In the US, the firm posted record gold production in the three months to end September, at 7,847 gold ounces, up 51% compared to the previous quarter. Meanwhile, over in Mexico, the firm produced 4,728 ounces of gold, 324,592 ounces of silver, 428 tonnes of copper, 2,157 tonnes of lead and 5,538 tonnes of zinc in the third quarter. Net income for the period came in at around $5 million, up from $2.9 million in the same quarter of 2019, on revenue of $42.2 million, up from around $40 million in the same period of 2019. XPhyto Therapeutics Corp (CSE:XPHY) (OTCMKTS:XPHYF) (FRA:4XT) said Tuesday that its German subsidiary Vektor Pharma TF GmbH will start to develop a process to manufacture psilocybin as a certified active pharmaceutical ingredient (API). The subsidiary inked a research agreement with a leading German university that will see Vektor exclusively develop a proprietary process for industrial production of psilocybin, Vancouver-based XPhyto told investors. In a statement, XPhyto said it is currently focused on securing industrial-scale production of psychedelic APIs and standardizing drug formulations. A biotechnology production program started last month and is expected to finish around September 2021.  NexTech AR Solutions Corp (OTCQB:NEXCF) (CSE:NTAR) (FRA:N29) announced Friday that it is expanding its services into the Asia-Pacific market after establishing a presence in Singapore. To support this expansion, NexTech said it has hired Yau Boon Lim, a technology industry veteran with over 25 years’ experience in strategy, planning, marketing, operations, and business management for various industries in the Asia-Pacific market. Lim has held leadership positions within global enterprise technology companies, driving marketing and strategies for blue-chip global tech companies, including IBM, where he led marketing management, Motorola where he was head of strategy and planning, and SAP where he was vice president of marketing for the Asia-Pacific market. Lim will be based out of Singapore. In this new role, Lim will be responsible for quickly establishing NexTech’s presence in the Asia-Pacific market through strategic channel partnerships. Lim will also drive the company’s marketing efforts across Asia and will build out the team to support service requests across the region by the end of 2020. O3 Mining Inc (CVE:OIII) announced new drilling results from the Malartic Property in Val D'Or, Quebec, which included 2.9 grams per tonne (g/t) gold over 14.2 metres starting at 25 meters below surface. O3 Mining’s latest drill results are part of its fully-funded 150,000 metre drilling program, which is focused on expanding mineralization outside of the proposed pit areas outlined in the Preliminary Economic Assessment (PEA) released on September 8 , 2020. The 2020-2021 drilling program encompasses 45,000 metres on the Malartic property to test extensions of the deposits and zones outside of the PEA pit areas of the Marban project. Jay Taylor, in the October 15, 2020, edition of 'Gold, Energy & Tech Stocks', says buy Fury Gold Mines Ltd. (CVE:FURY). He previously recommended predecessor company, Auryn Resources, nine times from March 16, 2015, to May 14, 2020, at prices ranging from $1.25 to $3.19. On October 9, 2020, Auryn completed a reorganization that created three companies, one of which was Fury (the other two are not publicly listed). For portfolio purposes, Taylor sold his $9,000 investment in Auryn on October 9, 2020, at $3.23, for a profit of $7,243. Now the focus turns to Fury, he said, with its core assets comprising the Eau Claire gold project in Quebec, the Committee Bay gold project in Nunavut and the Homestake Ridge gold project in British Columbia's Golden Triangle. Taylor said all three projects have "considerable growth potential." He is optimistic that Fury's "strong management team" is "setting the stage for some very positive developments over the next 12 months or so." Aftermath Silver Ltd (CVE:AAG) said the TSX Venture Exchange has accepted for filing an acquisition agreement dated September 30, 2020, between the company and SSR Mining Inc., whereby the company will acquire 100% of the Berenguela silver-copper project, located in Puno, Peru, through the purchase of 100%  of SSR's shares in the Peruvian holding company, Sociedad Mineral Berenguela S.A. The aggregate consideration is US$13 million, 3,828,972 common shares with a deemed price per share of 78.35 cents in the first year, and the completion of a preliminary feasibility study and filing of a National Instrument 43-101 report in the fifth year. The company will grant SSR a net smelter return (NSR) royalty, of which a 1% NSR royalty will be on all mineral production when the silver market price is up to and including US $25 per ounce, and a 1.25% NSR royalty will be on all mineral production when the silver market price is over US$25 per ounce and the copper market price is over US$2 per pound. Elysium Mining Ltd. (Peter Voulgaris) will receive a finder's fee of 191,448 common shares with a deemed price per share of 78.35 cents. TRACON Pharmaceuticals (NASDAQ:TCON) will reveal its 3Q 2020 results on Tuesday November 10 after the market closes. The San Diego-based firm’s management will also host a conference call to discuss the results at 4:30pm ET. Participants may log on by dialing (855) 779-9066 (Domestic) or (631) 485-4859 (International) and using the passcode 7399456. TRACON develops targeted therapies for cancer utilizing a capital efficient, CRO independent, product development platform. Milestone Scientific Inc (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, will host a conference call at 8:30am ET on November 17 to discuss the company’s financial results for the third quarter ended September 30, as well as its corporate progress and other developments. The conference call will be available on www.milestonescientific.com, or via telephone by dialing toll free 877-407-0778 for US callers or +1 201-689-8565 for international callers. A webcast will also be archived on the company’s website and a telephone replay of the call will be available approximately one hour following the call, through December 1 and can be accessed by dialing 877-481-4010 for US callers or +1 919-882-2331 for international callers and entering the pass code: 38544. Orgenesis Inc (NASDAQ:ORGS) announced Tuesday that due to the public health impact of the COVID-19 pandemic and to support the health and well-being of its stockholders, the 2020 Annual Meeting, scheduled for November 18 at 10 am ET, will be held instead in a virtual-only format. To attend and participate in the AM, stockholders of record as of the close of business on September 21 may visit the virtual event link provided in their proxy notice and use the control number received to log into the website. Stockholders will have the opportunity to vote and ask questions during the AM by following the instructions available on the meeting website. For stockholders who have already voted, no action is required. Stockholders may log into the website 15 minutes prior to the meeting start time. A support line will also be available during the AM should stockholders require assistance. Digital copies of the company’s proxy statement and 2019 Annual Report are available on its website at www.orgenesis.com, and will also be available on the webcast.